Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Vascular surgeon indicted for murder of ex-wife and her husband
Michael McKee is accused of making the journey from Illinois to Ohio and then shooting the two victims in their home on Dec. 30. He was arrested after surveillance footage showed his car at the scene before and after the murders.
Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD
Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.
Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent
The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment.
FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure
Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.
FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths
Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately.

Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings.

‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately.

court judge gavel business man bankruptcy lawsuit

Judge blocks Edwards’ JenaValve acquisition—FTC calls it a ‘major win’ for Trump administration

The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed.

FDA announces supplement recall over risk of heart attack or stroke

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Nirat Beohar, MD, director, cardiac catheterization laboratory, medical director of the structural heart disease program, Mount Sinai Medical Center in Miami Beach, Florida, and a professor at the Columbia University Division of Cardiology, explains the financial landscape of the cath lab, what is ahead, and why cardiologists need to become more business savvy. #TCT

The business of cardiology is changing—and cath labs are working to keep up

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

leg veins chronic venous disease PAD peripheral artery disease

Cardiovascular health societies share new performance and quality measures for PAD management

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

Newsweek ranked the 50 best heart hospitals in the world

Cardiologists perform first procedure of its kind to prevent coronary obstruction after TAVR

A vulnerable heart patient required TAVR, but he faced an extremely high risk of coronary obstruction. Leaflet modification and snorkel stenting were not possible, so the group turned to a brand new treatment option: the VECTOR procedure.

Clinical

Vascular surgeon indicted for murder of ex-wife and her husband

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure

FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths